Schedule of reconciliation of net income and the number of shares used in the basic and diluted net income per common share calculations: |
| | | | | | | | | | | | | | | Thirteen Weeks Ended | | Thirty-Nine Weeks Ended | | | January 1, | | December 26, | | January 1, | | December 26, | | | 2022 | | 2020 | | 2022 | | 2020 | Numerator: | | | | | | | | | | | | | Net income | | $ | 13,693 | | $ | 19,669 | | $ | 58,560 | | $ | 23,199 | Denominator: | | | | | | | | | | | | | Weighted-average common shares — basic | | | 49,611,468 | | | 48,570,843 | | | 49,386,897 | | | 48,491,286 | Nonvested restricted stock awards and other dilutive securities | | | 686,633 | | | 942,382 | | | 923,423 | | | 458,967 | Weighted-average common shares — diluted | | | 50,298,101 | | | 49,513,225 | | | 50,310,320 | | | 48,950,253 | | | | | | | | | | | | | | Net income per common share — basic | | $ | 0.28 | | $ | 0.40 | | $ | 1.19 | | $ | 0.48 | Net income per common share — diluted | | | 0.27 | | | 0.40 | | | 1.16 | | | 0.47 | Antidilutive securities not included: | | | | | | | | | | | | | Stock options outstanding | | | 1,654,260 | | | 1,895,557 | | | 1,714,940 | | | 1,965,591 | Nonvested restricted stock awards | | | 97,831 | | | — | | | 125,239 | | | 74,291 |
|